Friday, October 26, 2018

Experimental drug more effective in treating rare kidney disease

New study finds that experimental drug sparsentan is an effective treatment for the rare kidney disease focal segmental glomerulosclerosis, which currently has no FDA-approved therapies.

from Latest Science News -- ScienceDaily https://ift.tt/2OSHxYJ
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Millions of exploding stars could soon reveal dark energy's secrets

A new AI-powered framework could transform how astronomers measure the expansion of the Universe. By analyzing images of Type Ia supernovae ...